**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**



CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
  SECURITIES EXCHANGE ACT OF 1934

Date of report: January 22, 2007
  Date of earliest event reported: January 22, 2007

**PFIZER INC.**
  (Exact name of registrant as specified in its charter)

|**Delaware**                                                                                       | **1-3619**               | **13-5315170**                      
|-------------------------------------------------------------------------------------------------- | ------------------------ | ------------------------------------
|(State or other Jurisdiction of incorporation)                                                     | (Commission File Number) | (I.R.S. Employer Identification No.)
|**235 East 42nd Street 
          New York, New York**(Address of principal executive offices)**** |                          | **10017**
        (Zip Code)        

> Registrant's telephone number, including area code:(212) 573-2323 **Not Applicable**
>       (Former Name or Former Address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended
  to simultaneously satisfy the obligation of the registrant under any of the
  following provisions (see General Instruction A.2. below):

[ ] Written communication pursuant to Rule 425 under the Securities Act (17
  CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
  CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
  Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
  Act (17 CFR 240.13e-4(c))



|**Item 8.01**                                                                                                                                                                                                                                                                                                                                                                                                  | **Other Events**
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------
|On January 22, 2007, Pfizer Inc. (“Pfizer”)
        issued a press release relating to its meeting with financial analysts
        to discuss Pfizer's strategic direction. The information contained in
        the press release is deemed to be “filed” under the Securities
        Exchange Act of 1934 as Exhibit 99 to this report, and such press release
        is incorporated herein by reference.
|                                                                                                                                                                                                                                                                                                                                                                                                              

|**Item 9.01** | **Financial Statements and Exhibits** | 
|------------- | ------------------------------------- | 

|(d) Exhibits |                                                      | 
|------------ | ---------------------------------------------------- | 
|Exhibit 99   | Press Release of Pfizer Inc., dated January 22, 2007 | 



**SIGNATURE**

Under the requirements of the Securities Exchange Act of 1934, the registrant
  has caused this report to be signed on its behalf by the authorized undersigned.

|                        |  | PFIZER INC.                                                                                                 
|----------------------- |  | ------------------------------------------------------------------------------------------------------------
|                        |  |                                                                                                             
|                        |  | By: /s/ Margaret M. Foran
        Margaret M. Foran                                                         
|                        |  | Title: Senior Vice President-Corporate
        Governance, Associate General Counsel and Corporate Secretary
|Dated: January 22, 2007 |  |                                                                                                             

> 

EXHIBIT INDEX

|Exhibit No. | Description                                          
|----------- | -----------------------------------------------------
|            |                                                      
|99          | Press Release of Pfizer Inc., dated January 22, 2007.